From pulmonary vascular remodeling and increased pulmonary arterial pressure to right ventricular dysfunction, our pulmonary hypertension models support the evaluation of disease mechanisms and therapeutic candidates. IPS Therapeutique helps sponsors generate robust preclinical data to advance promising treatments with confidence.